Michael Otterstatter

Emmes (United States) — United States

Mathematics · Physical Sciences

26h-index3.0kcitations102works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 epidemiological studies(23), Plant and animal studies(15), Opioid Use Disorder Treatment(13), Insect and Pesticide Research(12), Substance Abuse Treatment and Outcomes(9)

Publications102 total

Exposure to Agent Orange and Association with Myelodysplastic Syndromes
Blood Advances·2026Open Access
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study
Blood Advances·2026Open Access
A clinical trial loses access to some of its experimental treatment conditions: What can be done?
Journal of Substance Use and Addiction Treatment·2025Open Access
Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study
Blood·2025Open Access
Exposure to agent orange and risk of myelodysplastic syndromes
Blood·2025Open Access
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)
Contemporary Clinical Trials·2025· 2 citedOpen Access
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction services
BMJ Open·2025· 1 citedOpen Access
Association between Smoking Intensity, Genetic Mutations, and Disease Progression in Myelodysplastic Syndromes
Blood·2024
Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS)
Blood·2024· 1 citedOpen Access
High-Risk Ccus Is Clinically Indistinguishable from Low-Risk Myelodysplastic Syndromes/Neoplasms
Blood·2024· 4 citedOpen Access
Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada
Harm Reduction Journal·2024Open Access
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial
Contemporary Clinical Trials·2024· 1 citedOpen Access
Visible minority status and occupation were associated with increased COVID-19 infection in Greater Vancouver British Columbia between June and November 2020: an ecological study
Frontiers in Public Health·2024· 3 citedOpen Access
Optimizing Retention Strategies for Opioid Use Disorder Pharmacotherapy: The Retention Phase of the Ctn-0100 Trial (RDD)
SSRN Electronic Journal·2024Open Access
A Review on Microbiological Source Attribution Methods of Human Salmonellosis: From Subtyping to Whole-Genome Sequencing
Foodborne Pathogens and Disease·2023· 7 citedOpen Access
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
Blood Advances·2023· 9 citedOpen Access
Forest Disturbance and Disease: Exploring the Effects of Tree Harvesting Area on <i>Cryptococcus gattii</i> sensu lato Infection Risk, Vancouver Island, Canada, 1998–2014
Environmental Health Perspectives·2023· 4 citedOpen Access
Understanding the impact of mobility on COVID-19 spread: A hybrid gravity-metapopulation model of COVID-19
PLoS Computational Biology·2023· 14 citedOpen Access
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
Blood Advances·2023· 12 citedOpen Access
Canada's Provincial Covid-19 Pandemic Modelling Efforts: A Review of Mathematical Models and Their Impacts on the Responses
SSRN Electronic Journal·2023· 3 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Naveed Z. Janjua(12), James D. Thomson(8), Daniel Coombs(7), Sarafa A. Iyaniwura(7), Michael A. Irvine(6), Caroline Colijn(6), Sunny Mak(6), Eleni Galanis(6), Jane A. Buxton(5), Robert Balshaw(5), Rebeca Cardim Falcão(5), Héctor Alexander Velásquez García(5), Robert J. Gegear(4), Sean C. Anderson(4), Nicola Mulberry(4), Jessica E. Stockdale(4), James Wilton(4), Prince Adu(4), Sheila R. Colla(3), Margot Kuo(3)